id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-P-0156-0004,FDA,FDA-2001-P-0156,"FDA/CDER to American Pharmaceutical Partner, Inc.",Other,LET-Letter,2002-05-16T04:00:00Z,2002,5,,,2008-04-25T02:25:53Z,,0,0,09000064804df2a5
FDA-2001-P-0156-0003,FDA,FDA-2001-P-0156,FDA,Notice,N-Notice,2002-05-15T04:00:00Z,2002,5,,,2008-04-25T02:25:53Z,,0,0,09000064804df2a2
FDA-2001-P-0156-0002,FDA,FDA-2001-P-0156,FDA/CDER to Tom Stothoff,Other,LET-Letter,2001-07-27T04:00:00Z,2001,7,,,2008-04-25T02:25:53Z,,0,0,09000064804df2a0
FDA-2001-P-0156-0001,FDA,FDA-2001-P-0156,FDA/DDM to Tom Stothoff,Other,ACK-Acknowledgement Letter,2001-02-02T05:00:00Z,2001,2,,,2008-04-25T02:25:53Z,,0,0,09000064804df23f